The extended pharmaceutical enterprise

被引：17

作者：

Cavalla, D ^{[1
]}

机构：

[1] Arachnova, St Johns Innovat Ctr, Cambridge CB4 0WS, England

来源：

DRUG DISCOVERY TODAY | 2003年 / 8卷 / 06期

关键词：

D O I：

10.1016/S1359-6446(03)02634-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The availability of widespread contractual services led to the birth of the virtual company in the 1990s. As the concept has matured, and the biotechnology sector diversified, interchange of intellectual property in the form of collaborative and license arrangements opens up still further the opportunities for outsourced forms of pharmaceutical RD.

引用

页码：267 / 274

页数：8

共 15 条

[1]

ABBOTT H, 2002, EUROPEAN BIOPHAR WIN, P31

[2]

[Anonymous], MODERN STRATEGY PREC

[3]

ANSELL J, 2001, SCRIP MAGAZINE MAY, P21

[4]

ARLINGTON S, 1998, PHARMA 2005 IND REVO

[5]

Cavalla D, 1997, DRUG NEWS PERSPECT, V10, P197

[6]

Cavalla D, 1997, DRUG NEWS PERSPECT, V10, P470

[7]

CAVALLA D, 1998, ANNU REP MED CHEM, V33, P365

[8] Quo vadis, biotech?: (Part 1) [J].

Drews, J .

DRUG DISCOVERY TODAY, 2000, 5 (12) :547-553

[9]

EDWARDS M, 1999, SIGNALS MAGAZINE

[10]

*IMS HLTH SG COW, 2002, IMS HLTH SG COW PHAR

← 1 2 →